Abstract:Background: To investigate the clinical and molecular characteristics of Chinese children with maturity onset diabetes of the young (MODY). Methods: A total of 42 Chinese patients suspected MODY referred to our unit from 2014 to 2018 were enrolled. Mutational analysis of monogenic diabetes mellitus genes was performed by next-generation sequencing and confirmed by Sanger sequencing. Results: There were 28 males (66.7%) and 14 females (33.3%) with a mean age of 9.49 +/- 3.46 years (range, 1.4-15.3 years) and a mean birth weight of 3.38 +/- 0.49 kg (range, 2.55-4.90 kg). Among these patients, 15 patients had polyuria, polydipsia or weight loss. Two patients (4.8%) were obese and six (14.3%) were overweight. Moreover, 13 patients (30.9%) had a family history of diabetes. Thirty variants were identified in 28 patients. Twenty-six variants in 25 patients were pathogenic or likely pathogenic genes (59.5%, 25/42), including 15 patients (60.0%, 15/25) with GCK mutation, four (16.0%, 4/25) with PAX4 mutation, three (12.0%, 3/25) with HNF4A mutation, one (4.0%, 1/25) with INS mutation, one (4.0%, 1/25) with NEUROD1 mutation and one (4.0%, 1/25) with HNF1A mutation. Nine mutations (36.0%, 9/25) were novel. There was no difference between mutation-suspected patients and MODY-confirmed patients except for a 2-h glucose increment in an oral glucose tolerance test (OGTT), while the GCK-MODY had lower glycated hemoglobin (HbA(1C)) and a significantly smaller 2-h glucose increment in an OGTT compared with transcription factor MODYs. The GCK-MODY was identified by incidental hyperglycemia without glycosuria. GCK-MODY without drug management and hepatocyte nuclear factor-1 alpha (HNF4A) or HNF1A-MODY with sulfonylurea therapy obtained good glucose controlling. Conclusions: Mutation of the GCK gene is the most common in MODY patients in China followed by PAX4. The screening criteria can improve the cost-effectiveness of disease diagnosis and treatment. A precise molecular diagnosis would lead to optimal treatment of the patients.

Contribution of MODY6 Gene in the Pathogenesis of Familial Type 2 Diabetes in Chinese Population

[Contribution of MODY2 Gene to the Pathogenesis of Chinese Early Onset Familial Type 2 Diabetes].

The contribution of MODY3 gene to the pathogenesis of early onset familial type 2 diabetes in Chinese population

Variations of Mitochondrial Gene ATP6 in Type 2 Diabetes Mellitus

Molecular Scanning for MODY5 Mutation in Beijing Population of Familial Early-Onset Type 2 Diabetes

The Pro~(12) → Ala Substitution in PPARγ_2 Gene May Be a Protective Factor for the Development of Type 2(diabetes) in Chinese Han Population

Molecular Scanning on MODY2 Genes in Early Onset Familial Type 2 Diabetes

[Molecular Scanning of MODY1 Gene Mutations in Pedigrees of Early Onset Type 2 Diabetes in Beijing].

Screening for Mutations of MODY 1-5 Genes in Chinese Families with Early-onset Type 2 Diabetes

Recognition of Maturity‐onset Diabetes of the Young in China

Evaluation of variant A45T in NEUROD1/BETA2 for its association with type 2 diabetes mellitus

A novel nonsense mutation c.747C>G in the NEUROD1 gene detected within a Chinese family affected by maturity‐onset diabetes of the young type 6

Associations of Common Variants in Methionine Metabolism Pathway Genes with Plasma Homocysteine and the Risk of Type 2 Diabetes in Han Chinese

Gck Mutations in Chinese Mody2 Patients: A Family Pedigree Report and Review of Chinese Literature

The Clinical Characteristic of the Familial Early Onset Type 2 Diabetes Mellitus and Study of MODY_1 Genes Mutation

Uncoupling Protein 2 and Peroxisome Proliferator-Activated Receptor γ Gene Polymorphisms in Association with Diabetes Susceptibility in Chinese Han Population with Variant Glucose Tolerance

Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population

Maturity Onset Diabetes of the Young (MODY) in Chinese Children: Genes and Clinical Phenotypes

Prevalence and Clinical Characteristics of PDX1 Variant Induced Diabetes in Chinese Early-Onset Type 2 Diabetes

Exon Sequencing of HNF1β in Chinese Patients with Early-Onset Diabetes

Identification of Maturity-Onset Diabetes of the Young Caused by Mutation in FOXM1 via Whole-Exome Sequencing in Northern China